Role of biosimilar introduction on insulin glargine prices: a retrospective analysis in 28 European countries

Objective Quantify insulin glargine prices following the market introduction of biosimilars. Examine price levels and price changes for originator and biosimilars, by country.Methods Retrospective quantitative analysis using insulin glargine pricing data, both of the originator product and its biosi...

Full description

Saved in:
Bibliographic Details
Main Authors: David Beran, Margaret Ewen, Mario Raviglione, Tido von Schoen-Angerer, Davide Morolla
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/15/1/e090484.full
Tags: Add Tag
No Tags, Be the first to tag this record!